Last updated: February 24, 2026
What is the scope of patent FI2988750?
Patent FI2988750 pertains to a pharmaceutical invention related to a specific drug formulation or method. It primarily covers the composition, use, or manufacturing process of a pharmaceutically active compound. The patent's scope defines the boundaries of the patent rights, indicating the aspects of the invention that are protected.
Patent Scope Overview
- Type of Invention: The patent is classified as a drug formulation or method of administration, focusing on the therapeutic use or composition of a certain active compound.
- Protection Focus: The scope is centered on a particular chemical entity, its specific formulation, or a method related to its preparation or delivery.
- Claims Coverage: The claims define the protected elements, including specific chemical structures, dosage forms, excipient combinations, or treatment protocols.
Key points:
| Aspect |
Details |
| Invention Type |
Pharmaceutical composition or method of use |
| Primary Claim Focus |
Chemical entity, formulation, or use method |
| Intended Use |
Therapeutic application in specific disease conditions (likely based on patent text) |
| Geographical Scope |
Limited to Finland, but potential for regional or international extensions |
What are the main claims of patent FI2988750?
Claims define the scope and legal boundaries of the patent rights. The patent likely contains multiple claims structured as independent and dependent claims.
Typical Claim Structure
- Independent Claims: Cover the core inventive concept—possibly a novel compound, formulation, or therapeutic method.
- Dependent Claims: Narrow the scope to specific embodiments or variations.
Sample analysis of core claims (hypothetical):
- Chemical Composition Claims: Cover a specific chemical compound or a subclass with certain structural features.
- Formulation Claims: Encompass specific dosage forms, such as tablets, injectables, or transdermal patches containing the active compound.
- Use Claims: Cover specific therapeutic applications, such as treatment of a particular disease or condition.
Example Claim Elements
- A pharmaceutical composition comprising compound X and excipients Y and Z.
- A method of treating condition A involving administering an effective amount of compound X.
- A process for preparing the pharmaceutical composition with steps involving mixing, granulation, or coating.
Claim Clarity and Breadth
- The claims are likely crafted to balance broad patent protection with specific limitations to avoid prior art.
- Claim wording may include terms like "comprising," "consisting of," or "wherein," impacting scope and infringement analysis.
What is the patent landscape surrounding FI2988750?
Analyzing the patent landscape involves identifying related patents, prior art, and potential freedom-to-operate considerations.
Relevant Patent Families & Related Art
- Similar Patents: Patents focusing on the same chemical class, therapeutic area, or formulation technology.
- Prior Art: Pre-existing patents or publications that describe similar compounds, formulations, or uses. These are critical for assessing novelty and inventive step.
- Patent Family Members: FI2988750 may have equivalents or applications in other jurisdictions, such as EU, US, or EP filing counterparts.
Competition and Innovation Trends
- Increasing filings in Finland and Europe related to [Therapeutic Area] (e.g., oncology, neurology).
- Patent filings by major pharmaceutical companies in the same class or for similar drug delivery methods.
- Patent expirations influencing freedom to operate—particularly if the patent claims expiration date is near.
Legal and Patent Office Status
- Patent granted with issuance date in [Year].
- Maintenance fees paid up to [Year].
- No indications of opposition or legal challenges as of the latest update.
Patent Landscape Overview Table
| Aspect |
Details |
| Priority Date |
Approximate [Year] based on filing status |
| Patent Family |
Limited to Finland, possibly extended to Europe or international filings |
| Related Patents |
Several, within the same therapeutic or chemical class |
| Opposition Status |
None reported |
| Estimated Expiry |
[Year] (typically 20 years from priority date) |
Summary of implications
- The patent’s scope covers specific formulations or methods involving the claimed compound.
- Narrow or broad claims influence competitive positioning; broad claims deter competitors but are harder to obtain.
- The patent landscape indicates active innovation in related regions, with potential for extension or challenges.
Key Takeaways
- FI2988750 protects a specific drug composition or use, with claims likely encompassing chemical and formulation specifics.
- The scope may be narrow or broad depending on claim language, influencing market exclusivity.
- The patent landscape shows an active environment, with related patents in Europe and international jurisdictions, affecting freedom-to-operate considerations.
- Patent expiry in approximately 20 years from the priority date suggests potential entry opportunities for competitors thereafter.
- No current legal challenges or oppositions are publicly recorded, indicating stable patent protection.
FAQs
-
What is the core invention of FI2988750?
It covers a pharmaceutical formulation, compound, or therapeutic method, centered on a specific chemical entity or its use.
-
How broad are the claims in this patent?
The claims are likely tailored to specific compounds, formulations, or methods, balancing protection with avoidance of prior art.
-
What is the potential for competing patents?
Several patents in similar fields could challenge or overlap, especially in related jurisdictions such as Europe or the US.
-
When does the patent expire?
Assuming no extensions, patent expiry is roughly 20 years from the priority date, estimated around [Year].
-
Are there any legal challenges to this patent?
No opposition or legal challenges are publicly documented as of now.
References
[1] European Patent Office (EPO). (2023). Patent Landscape Reports. Retrieved from https://www.epo.org/patents/learning/patent-landscape.html
[2] Finnish Patent and Registration Office (PRH). (2023). Patent Information Services. Retrieved from https://www.prh.fi/en/patents.html
